OSR Health, Inc. OSRH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -50.24% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -50.24% | -- | -- | -- | -- |
| Cost of Revenue | -62.13% | -- | -- | -- | -- |
| Gross Profit | 22.77% | -- | -- | -- | -- |
| SG&A Expenses | 21.35% | -- | -- | -- | -- |
| Depreciation & Amortization | 37.70% | -- | -- | -- | -- |
| Other Operating Expenses | 30.43% | -- | -- | -- | -- |
| Total Operating Expenses | 10.24% | -- | -- | -- | -- |
| Operating Income | -26.73% | -- | -- | -- | -- |
| Income Before Tax | 19.50% | -- | -- | -- | -- |
| Income Tax Expenses | -361.15% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.04% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.74% | -- | -- | -- | -- |
| Net Income | 31.91% | -- | -- | -- | -- |
| EBIT | -26.73% | -- | -- | -- | -- |
| EBITDA | -57.26% | -- | -- | -- | -- |
| EPS Basic | 86.83% | -- | -- | -- | -- |
| Normalized Basic EPS | 82.53% | -- | -- | -- | -- |
| EPS Diluted | 86.83% | -- | -- | -- | -- |
| Normalized Diluted EPS | 82.53% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 268.01% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 268.01% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |